8/12/2019 Cll Presentation
1/21
Values Innovations
8/12/2019 Cll Presentation
2/21
Year of Establishment: 19th Nov 1997
Founder: Dr.A.N.Singh
Managing Director and Chairman
ISO 9001 2008 Certified Company
The R&D facility is recognized by DSIRMember of AIBA
Origin
8/12/2019 Cll Presentation
3/21
Vision
To be a leading global Bio Pharmaceutical
company driven by technology, innovation
and applied research & developmentmechanism.
8/12/2019 Cll Presentation
4/21
Celestial Bio Labs Focus
Bio Pharmaceuticals
Herbal
Formulation
Allopathic
Formulation
Biotech
Formulation
Drug Development
Bio tools
Bio Informatics
IPR IPR
8/12/2019 Cll Presentation
5/21
Biopharmaceuticals
Herbal, Allopathic and Biotech formulation
Bioinformatics
Molecular Modeling
Customized ERP dedicated to Healthcare
and retail chain
New Drug Molecule development and testing
Clinical trial & Clinical Data ManagementServices
Our Expertise
8/12/2019 Cll Presentation
6/21
A) BIO-SERVICES
Gene sequence analysis
Molecular modeling
Clinical data management
Pharmaco vigilance Medical writing
ERP focused to pharma manufacturing
B) BIO PHARMACUTICAL FORMULATION
Herbal , Allopathic and Enzyme formulations
Our Business
8/12/2019 Cll Presentation
7/21
Research Center :Bio Tool and Data Base Development
Biomolecules development:
Four New molecules with focus on Vitiligo, Wound healing,
Anti wrinkling and Tanning.
Neutraceuticals, Herbals and enzyme formulations.
Accelerating Clinical Development :
Both in-house and through partnerships
Developing Allopathic drugs through bio similar approach
and organizing clinical trailsFocus:
Core therapeutic areas with a project-based approach
Scientists:
Over 15
Research & Development
8/12/2019 Cll Presentation
8/21
Dedicated and committed management team
Experienced scientists and technical team
ISO 9001 2008 Certified
New Drug development through Bioinformatics and
Bio Similar
Technological collaboration with leading research
institutions
IPR Generations
Key Strengths
8/12/2019 Cll Presentation
9/21
Bio-IT Tools and Packages (6 nos)
Patents Under Process
Vitiligo new drug molecule
(12 nos) for different therapeutic application
concerning Herbal formulation
INTELLECTUAL PROPERTY RIGHTS (IPR)
8/12/2019 Cll Presentation
10/21
OSMANIA
JNTU
IMTECH
IICT
CCMB
NIPER
Research Interaction
8/12/2019 Cll Presentation
11/21
SHORT TERM:
Scaling of Existing Bio-Informatics/Informatics services
dedicated to pharma, chemical, biotech, medical centers,
hospitals and medicine retail chains.
Manufacturing and marketing of herbal, allopathic andBiotech formulations in India and overseas.
Developing and Promoting Nutraceuticals in INDIA and
Over Seas
LONG TERM:
Developing a range of medicines that has become off patent by
introducing important Phyto chemical/Herbal/Enzyme to
improve the efficacy and also to reduce side effects in order to
make it patentable medicine through bio similar approach .
BusinessStrategy
8/12/2019 Cll Presentation
12/21
I
NT
E
G
R
AT
E
D
E
FF
O
R
T
STRATERGIC
VALUE CHAIN
LONGTERM
COST
COMPETITIVENESS
LEAVERAGE
INNOVATIONPRODUCTION
&
OPERATIONAL
EFFIENCY
BUSINESS
DEVELOPMENT
AND
MARKETING
INTELLECTUAL
PROPERTY RIGHTS
INNOVATION
Bioservices
Bioneutraceuticals
Custom Enzyme &
Biotech Formulation
Manufacturing
Business
Intelligence
ERP(BIO PHARMCUTICAL)
Integrated Business Model
8/12/2019 Cll Presentation
13/21
1. Committed to progressive governance.
2. Accredited by DSIR.
3. Commitment to highest standards ofdisclosures & transparency.
4. Company listed in both NSE & BSE.
5. Code of Business Ethics.
6. Compliance with all regulatory affairs .
Corporate Governance
8/12/2019 Cll Presentation
14/21
General features:R & D laboratory (Equipped forintegrated bench-topexperimentation and development)
Industrial Enzymes
Product and Quality control
Lab
Bioinformatics
model
LAB INFRASTRUCTURE
8/12/2019 Cll Presentation
15/21
Board of DIRECTORS
Dr. A.N. Singh
B.tech, MBA, PhD (Technology Management With 3 Decades of
experience).
Dr. B.Siva Kumar
PhD in nutrition science with 35 yrs of experience.
Dr. Jeetainder Gour
PhD in Ayurveda with 12 yrs of experience.
Mrs. Padma SinghGraduate & Actively participating in Social works from last 15 yrs.
8/12/2019 Cll Presentation
16/21
Dr. A.N. Singh
Bio Informatics experience in developing new drug molecules &conducting clinical trails
Dr. G.Bala Krishna
Extensive R&D experience in computer modeling, drug discovery &
clinical trails
Dr. Rama KrishnaR & D Experience in developing new Herbal formulations and
clinical trail management. Extensive working in Syrup, Tablet,
Capsules, Ointment & Granules.
Mr. B.Hari babu06 yrs of Design & Technology Integration
Mr. A. Anil Reddy
04 yrs of Design & Development of Data base & also conducting
clinical data testing & analysis .
RESEARCH & DEVELOPMENT GROUP
8/12/2019 Cll Presentation
17/21
FINANCE & ADMINISTRATION
Mr. T.Ramesh (Senior Finance Manager)M.Com with 20 yrs of Accounting & Financial management
experience
Mr. P.Rama KrishnaB.Com with 15 yrs of Accounting & Financial management
experience
Mr. Arvind kumar
CFA with 8 yrs of Accounting , Financial management & Analyticalexperience
8/12/2019 Cll Presentation
18/21
FINANCIAL STATEMENT2012 2013 2014 2015 2016 2017 2018
Particulars Actuval Proj. Proj. Proj. Proj. Proj. Proj.
Domestic Sales (Gross) 21.02 24.59 31.82 35.63 43.03 45.27 50.25
Export Sales ---- 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 21.02 24.59 31.82 35.63 43.03 45.27 50.25
% rise/fall (-) in net sales 1.33 3.00 4.00 5.00 6.00 7.00 8.00
Operating Profit 2.92 2.86 7.26 9.35 14.61 14.23 16.43
Profit Before tax 0.28 2.86 7.26 9.35 14.61 14.23 16.43
PBT/ Sales (%) 0.00 11.64 22.83 26.25 33.95 31.44 32.69
Profit After Tax 0.21 2.29 5.26 6.51 9.87 9.53 10.90
Cash Accrual 0.10 6.50 9.82 11.08 14.44 14.10 15.46
PBDIT 4.02 9.67 14.80 16.39 21.14 20.26 21.95
Paid Up Capital 14.60 14.60 14.60 14.60 14.60 14.60 14.60
TNW 0.00 70.72 76.28 83.10 93.20 102.73 113.63
Adjusted TNW 0.00 70.72 76.28 83.10 93.20 102.73 113.63
TOL/TNW (times) 0.00 0.34 0.27 0.20 0.14 0.10 0.06
Adjusted TOL/TNW 0.00 0.34 0.27 0.20 0.14 0.10 0.06
NWC 0.00 -17.65 -11.11 -3.32 7.74 18.24 33.70
Current Ratio 27.46 -0.95 -0.22 0.64 1.84 2.95 6.77
TTL/TNW 0.00 0.21 0.15 0.09 0.04 0.01 0.00
Current ratio without TL repay 0.00 -1.59 -0.37 1.05 3.01 4.79 6.77
TOL/TNW (treating USL as 0.18 0.33 0.26 0.20 0.14 0.09 0.05
Quasi Equity)
8/12/2019 Cll Presentation
19/21
Mr. I.A. Chippa (Sale Manager)
B.SC (Biology) Two decades of sales & marketing experience inAllopathic & Herbal formulations. Product training & marketing
strategy is the key factor in his experience
Mr. Sunil Sharma, Mr.Pradeep khare, Mr. Avanti Das Mohapatra,Mr. Nitin j. Deshmukh, Mr. Madan Murari Pandey. (Regional
Sales Managers) along with their Area Sales managers and
Business development manager spread across INDIA
SENIOR MARKETING GROUP
8/12/2019 Cll Presentation
20/21
Create a congenial work environment.
Strict conformity to current Good Manufacturing Practices (CGMP) and
Good Laboratory Practices (CGLP).
Continued R&D efforts for continuous improvement and to find new
solutions.
Create a scientific base to promote innovative R&D programs.
To seek active collaborations / partnerships from leading organisations in
India and abroad to complement our strengths.
To respect intellectual property rights.
CORE VALUES
8/12/2019 Cll Presentation
21/21
MAILING ADDRESS:
CELESTIAL BIOLABS LIMITED
Plot No : 59, Road No : 12, APIIC Tech Park, IDA
Nacharam, Hyderabad-500076. A.P, INDIA
Phone : + 91 40 64565544, + 91 40 65552697
E-mail : [email protected] : www.celestialbiolabs.com
Top Related